Literature DB >> 23336058

Activation of 5-HT6 receptors modulates sleep-wake activity and hippocampal theta oscillation.

Susanna Ly1, Bano Pishdari, Ling Ling Lok, Mihaly Hajos, Bernat Kocsis.   

Abstract

The modulatory role of 5-HT neurons and a number of different 5-HT receptor subtypes has been well documented in the regulation of sleep-wake cycles and hippocampal activity. A high level of 5-HT(6) receptor expression is present in the rat hippocampus. Further, hippocampal function has been shown to be modulated by both 5-HT(6) agonists and antagonists. In the current study, the potential involvement of 5-HT(6) receptors in the control of hippocampal theta rhythms and sleep-wake cycles has been investigated. Hippocampal activity was recorded by intracranial hippocampal electrodes both in anesthetized (n = 22) and in freely moving rats (n = 9). Theta rhythm was monitored in different sleep-wake states in freely moving rats and was elicited by stimulation of the brainstem reticular formation under anesthesia. Changes in theta frequency and power were analyzed before and after injection of the 5-HT(6) antagonist (SAM-531) and the 5-HT(6) agonist (EMD386088). In freely moving rats, EMD386088 suppressed sleep for several hours and significantly decreased theta peak frequency, while, in anesthetized rats, EMD386088 had no effect on theta power but significantly decreased theta frequency, which could be blocked by coadministration of SAM-531. SAM-531 alone did not change sleep-wake patterns and had no effect on theta parameters in both unanesthetized and anesthetized rats. Decreases in theta frequency induced by the 5-HT(6) receptor agonist correspond to previously described electrophysiological patterns shared by all anxiolytic drugs, and it is in line with its behavioral anxiolytic profile. The 5-HT(6) antagonist, however, failed to potentiate theta power, which is characteristic of many pro-cognitive substances, indicating that 5-HT(6) receptors might not tonically modulate hippocampal oscillations and sleep-wake patterns.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23336058      PMCID: PMC3547479          DOI: 10.1021/cn300184t

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  82 in total

Review 1.  Electrophysiology of 5-HT6 receptors.

Authors:  Annalisa Tassone; Graziella Madeo; Giuseppe Sciamanna; Antonio Pisani; Paola Bonsi
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

2.  Control of hippocampal theta rhythm by serotonin: role of 5-HT2c receptors.

Authors:  Elin Sörman; Dannie Wang; Mihaly Hajos; Bernat Kocsis
Journal:  Neuropharmacology       Date:  2011-01-31       Impact factor: 5.250

3.  Median raphe stimulation disrupts hippocampal theta via rapid inhibition and state-dependent phase reset of theta-related neural circuitry.

Authors:  Jesse Jackson; Clayton T Dickson; Brian H Bland
Journal:  J Neurophysiol       Date:  2008-04-24       Impact factor: 2.714

Review 4.  Influence of social isolation in the rat on serotonergic function and memory--relevance to models of schizophrenia and the role of 5-HT₆ receptors.

Authors:  Charles A Marsden; Madeleine V King; Kevin C F Fone
Journal:  Neuropharmacology       Date:  2011-03-15       Impact factor: 5.250

5.  Raphe serotonin neurons are not homogenous: electrophysiological, morphological and neurochemical evidence.

Authors:  Lyngine H Calizo; Adaure Akanwa; Xiaohang Ma; Yu-Zhen Pan; Julia C Lemos; Caryne Craige; Lydia A Heemstra; Sheryl G Beck
Journal:  Neuropharmacology       Date:  2011-04-16       Impact factor: 5.250

6.  Effects of fluoxetine on hippocampal rhythmic slow activity and behavioural inhibition.

Authors:  Robert G K Munn; Neil McNaughton
Journal:  Behav Pharmacol       Date:  2008-05       Impact factor: 2.293

7.  Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats.

Authors:  Stephen R Morairty; Linda Hedley; Judith Flores; Renee Martin; Thomas S Kilduff
Journal:  Sleep       Date:  2008-01       Impact factor: 5.849

8.  Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.

Authors:  Lee E Schechter; Qian Lin; Deborah L Smith; Guoming Zhang; Qin Shan; Brian Platt; Michael R Brandt; Lee A Dawson; Derek Cole; Ron Bernotas; Albert Robichaud; Sharon Rosenzweig-Lipson; Chad E Beyer
Journal:  Neuropsychopharmacology       Date:  2007-07-11       Impact factor: 7.853

9.  Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia.

Authors:  Mihály Hajós; William E Hoffmann; Bernát Kocsis
Journal:  Biol Psychiatry       Date:  2008-02-07       Impact factor: 13.382

10.  Patterns of coupled theta activity in amygdala-hippocampal-prefrontal cortical circuits during fear extinction.

Authors:  Jörg Lesting; Rajeevan T Narayanan; Christian Kluge; Susan Sangha; Thomas Seidenbecher; Hans-Christian Pape
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

View more
  11 in total

Review 1.  Serotonergic modulation of hippocampal theta activity in relation to hippocampal information processing.

Authors:  María Esther Olvera-Cortés; Blanca Erika Gutiérrez-Guzmán; Elisa López-Loeza; J Jesús Hernández-Pérez; Miguel Angel López-Vázquez
Journal:  Exp Brain Res       Date:  2013-08-30       Impact factor: 1.972

2.  Prefrontal-hippocampal coupling by theta rhythm and by 2-5 Hz oscillation in the delta band: The role of the nucleus reuniens of the thalamus.

Authors:  Alexis Roy; Frans Pettersson Svensson; Amna Mazeh; Bernat Kocsis
Journal:  Brain Struct Funct       Date:  2017-02-16       Impact factor: 3.270

3.  Respiration-coupled rhythms in prefrontal cortex: beyond if, to when, how, and why.

Authors:  Bernat Kocsis; Benjamin R Pittman-Polletta; Alexis Roy
Journal:  Brain Struct Funct       Date:  2017-12-08       Impact factor: 3.270

4.  5-HT3a Receptors Modulate Hippocampal Gamma Oscillations by Regulating Synchrony of Parvalbumin-Positive Interneurons.

Authors:  Ying Huang; Kristopher Yoon; Ho Ko; Song Jiao; Wataru Ito; Jian-Young Wu; Wing-Ho Yung; Bai Lu; Alexei Morozov
Journal:  Cereb Cortex       Date:  2014-09-21       Impact factor: 5.357

Review 5.  Genetic Basis of Chronotype in Humans: Insights From Three Landmark GWAS.

Authors:  David A Kalmbach; Logan D Schneider; Joseph Cheung; Sarah J Bertrand; Thiruchelvam Kariharan; Allan I Pack; Philip R Gehrman
Journal:  Sleep       Date:  2017-02-01       Impact factor: 5.849

6.  Impairment of cognitive function by chemotherapy: association with the disruption of phase-locking and synchronization in anterior cingulate cortex.

Authors:  Li Mu; Jun Wang; Bing Cao; Beth Jelfs; Rosa H M Chan; Xiaoxiang Xu; Mahadi Hasan; Xu Zhang; Ying Li
Journal:  Mol Brain       Date:  2015-05-23       Impact factor: 4.041

7.  Distinct pro-vigilant profile induced in rats by the mGluR5 potentiator LSN2814617.

Authors:  Sally Loomis; Andrew McCarthy; Christopher Baxter; Daniel O Kellett; Dale M Edgar; Mark Tricklebank; Gary Gilmour
Journal:  Psychopharmacology (Berl)       Date:  2015-04-24       Impact factor: 4.530

8.  Reciprocal Interactions between Medial Septum and Hippocampus in Theta Generation: Granger Causality Decomposition of Mixed Spike-Field Recordings.

Authors:  Daesung Kang; Mingzhou Ding; Irina Topchiy; Bernat Kocsis
Journal:  Front Neuroanat       Date:  2017-12-12       Impact factor: 3.856

9.  Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.

Authors:  Sandor Kantor; Janos Varga; Shreya Kulkarni; A Jennifer Morton
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

10.  Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank.

Authors:  Jacqueline M Lane; Irma Vlasac; Simon G Anderson; Simon D Kyle; William G Dixon; David A Bechtold; Shubhroz Gill; Max A Little; Annemarie Luik; Andrew Loudon; Richard Emsley; Frank A J L Scheer; Deborah A Lawlor; Susan Redline; David W Ray; Martin K Rutter; Richa Saxena
Journal:  Nat Commun       Date:  2016-03-09       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.